Target identification and translation results in weeks, not years
Guarantee faster, more successful target discovery with Lifebit’s powerful software, designed to manage and analyze data in your own environment.
Trusted by the world's biomedical leaders
INACCESSIBLE DATA
10-18 months
To locate and access data as 80% of health data is unavailable for R&D
HIGH FAILURE RATE
90% fail
Of clinical drug developments fail due to poor understanding of the underlying disease mechanisms
SLOW RESULTS
1-3 years
for pre-clinical testing, research and development
INEFFECTIVE DIY
$10+ billions
wasted worldwide due to non-functional, DIY data platforms
Target Identification & Translation Challenges
THE FOUNDATION FOR SUCCESSFUL IDENTIFICATION AND TRANSLATION:
EFFICIENT, COMPLIANT, AND PROVEN DATA SOLUTIONS
Guaranteed Results for End-Users
Lifebit’s pioneering Trusted Research Environment (TRE) is the only TRE that guarantees results for life sciences.
Lifebit’s TRE is widely adopted by pharma, healthcare and major research institutions. Our pioneering Get Results™ Framework provides self-serve functionality for both code and no-code users, and the highest feature-release rate, to ensure rapid results to your evolving needs.
Self-Service, No Maintenance Required
Lifebit’s self-serve platform is ready to use, requiring no expensive third-party services or hours of professional support.
With advanced organizational management features like cost tracking, audit logs, and single sign-on (SSO) integration, your team can focus on discovery, not platform maintenance.
Fully Compliant with FDA RWE Requirements
Lifebit’s Trusted Data Lakehouse™ is the only lakehouse to meet stringent FDA real-world evidence (RWE) guidelines, offering complete audit trails, data lineage and provenance with each retrieval.
As the preferred partner of governments, Lifebit Trusted Data Lakehouse™ solution goes above and beyond enforcing FDA standards to further ensure data residency, 5-Safes, FedRAMP, GDPR, HIPAA, ISO, and SOC II compliance, among others
Most Efficient Data Solution for Faster Target Identification
Lifebit’s Al-powered data platform saves time by automating data cleaning, mapping, standardization and analysis.
With advanced data QA, cohort browsing, and interactive web tools, Lifebit’s platform reduces errors and streamlines discovery. Access customizable cataloging and harmonization, prioritizing datasets to meet your study needs. Combine proprietary data with the world’s largest federated data marketplace with >250M patients within a unified data layer.
Your data. Full control. Powering discovery.
Lifebit’s Trusted Research Suite provides discovery and translational teams with the solution to accelerate disease target identification, validation, and clinical trials. Combining the Federated Trusted Research Environment (TRE) and Trusted Data LakehouseTM, Lifebit’s solutions enable seamless management and analysis of high quality, usable data, with guaranteed results for drug discovery.
Trusted Data Lakehouse™ (TDL)
Effortlessly fetch, connect, harmonize, and catalog multi-modal biomedical data to power target identification and validation in one secure, AI-driven platform.
Manage your health data products effortlessly
Trusted Research Environment (TRE)
Enable your researchers to gain rapid insights and identify disease targets without moving data, ensuring full security and compliance.
Accelerate target identification and deliver insights securely
MEET LIFEBIT’S FEDERATED & TRUSTED RESEARCH SUITE™
Meet the pioneers.
Abbvie uses Lifebit’s platform to advance the search for new treatments for common chronic illnesses through population genomics research.
Ionis Pharmaceuticals use the Lifebit platform and a combination of deep phenotypic data and high-quality whole-genome sequencing to improve the understanding of fundamental disease mechanisms. This strategy has the potential to greatly accelerate the drug development process by translating targets into therapies faster.
J&J uses Lifebit’s platform to seek to understand differences in patient responses in autoimmune disorders to make it easier to target more specific patient subpopulations that could lead to the development of new treatment drugs.
The Lifebit platform empowers GSK to assess variability among patients with conditions including heart failure and liver disease and gain a deeper understanding of illness severity and symptoms. It is intended to make it easier to identify more focused patient subgroups, which could potentially allow for the advancement of particular therapeutic medicines in particular patient subgroups.
“This platform will play an important part of Boehringer Ingelheim’s broader strategy to capture translational disease insights from large external healthcare biobanks and ultimately to accelerate the development of innovative medicines.”
Dr. Jan Nygaard Jensen
SVP & Global Head of Computational Biology & Digital Sciences
Creating successful data products
Lifebit partners with Boehringer Ingelheim to capture insights from large external healthcare biobanks, accelerating the development of innovative medicines.
Customer Story: Boehringer Ingelheim
Ready to maximize the value of your data?
Contact Lifebit today and discover how our federated solutions can power your data.
We’ll respond as soon as possible.
